Steven M. Auvil is a partner and Chair of Benesch's Intellectual Property Practice Group.
This post is sponsored by Benesch. Newsflash — both houses of the U.S. Congress and the President agreed on something! Yes, our government agreed, by a wide margin, that it was necessary to modernize our patent laws and did so when it passed the Leahy-Smith America Invents Act or AIA on September 16, 2011. A […]
This post is sponsored by Benesch. Medical device and drug companies often contract with independent physicians to assist with product development. In the ideal situation, such physicians become external members of a product development team tasked with developing the next blockbuster product. When all goes according to plan, the team develops a safe and effective […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
This post is sponsored by Benesch. Valuation of a start-up is important for a variety of reasons. Obtaining capital, developing partnerships and preparing for an eventual exit strategy are just a few. Valuation is not an exact science but rather the result of judgments relating to the business, and those judgments are based on a […]
There are many exciting legislative and regulatory changes on the horizon relating to patents. As you have probably been hearing, President Obama is throwing his support behind these major changes as they promote job creation and economic growth. Now, the words “exciting” and “legislative/regulatory” are not usually used in the same sentence, but with the […]